Skip to main content

Health + Wellness

KL2 Scholar alum receives $7.2 million NIH grant to study transmission of tuberculosis in Uganda
Charles Bark, MD, CTSC KL2 Scholar alum and an infectious disease specialist in the MetroHealth Medical Center Department of Medicine, was awarded a 5-year $7.2 million NIH grant to study patterns of tuberculosis (TB) transmission in Kampala, Uganda. Decreasing the global burden of TB requires preve...
Daniel%20Ontaneda.jpg
Hero Type
Image
Interview with a KL2 Scholar alum: Exploring early multiple sclerosis treatment strategies
When it comes to initial treatment selection for relapsing-remitting multiple sclerosis (RRMS), there is one question that has yet to be answered: Is it better to start with potentially safer moderately effective disease-modifying treatments (DMTs) or to hit the disease immediately with a high-effic...
Musil%20Hickman%2C%20Voss%20Griffin%20with%20FPB%20alumni%20and%20colleagues.JPG
Hero Type
Image
CWRU’s work with Microsoft HoloLens highlighted
Outlet: Cleveland Magazine...
CTSC Regulatory Steering Group convened to promote city-wide interaction and collaboration
Faculty, staff members, and invited guests supporting research administration from all four of our partner institutions convened on Wednesday, August 14, 2019 for the CTSC Regulatory Steering Group Meeting. This gathering of over 20 individuals from Case Western Reserve University, the Cleveland Cli...
Director Stan Gerson Elected to National Academy of Inventors as Senior Member
The National Academy of Inventors (NAI) has named 54 academic inventors to the Spring 2019 class of NAI SeniorMembers, including Stan Gerson, MD, Director of the Case Comprehensive Cancer Center (Case CCC). NAI Senior Members are active faculty, scientists and administrators from its Member Insti...
Medicine’s Darcy Freedman discusses takeaways from food hub study and next steps
Outlet: Crain's Cleveland Business...
Company founded by CWRU’s Paul Tesar, Drew Adams partners with Genentech
Outlet: Crain's Cleveland Business...
A New Pathway: Researchers Identify Potential Treatment Target for Crohn’s Disease
There is no cure for the more than 1.6 million people in the United States living with Crohn’s disease (CD) and its symptoms, including abdominal pain, intestinal distress and severe weight-loss. CD is a form of inflammatory bowel disease (IBD) in which the body’s own immune system attacks the gastr...